FOR IMMEDIATE RELEASE San Carlos, California, United States of America (Free-Press-Release.com) May 9, 2013 -- Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that ...
Tags: Construction, Decoration
In the spirit of increasing awareness of the benefits of modern cloth diapers, Cutie Poops and Bottoms of Orland Park is helping children fighting cancer. The store recently participated in a worldwide event called The Great Cloth Diaper ...
Tags: Toys
ChemRar Ventures has entered into scouting agreement with Sanofi for a venture investment in Russia and Asia. As per the agreement, ChemRar Ventures will source early and late stage compounds within a certain defined area of Sanofi's ...
Co-Diagnostics has signed an agreement with DNA Logix, a molecular diagnostic assays developer, to buy certain technologies for genetic analysis in the clinical, industrial, and bio-threat segments. The technology to be gained is embodied ...
Tags: Suite of Technologies, Medicine
Sixteen years after inspiring his mother to create the Pediatric Oncology Treasure Chest Foundation, Martin Kisel is helping the non-profit expand nationally while reflecting on his two decades in remission. The 27-year-old helps his ...
Tags: Toys
Students at four District #210 Lincoln-Way high schools are participating in a program designed to make their local community a better environment in which to live, work and learn. T.E.A.M. Asset, an acronym for Teaching Everyone Assets ...
Tags: toys, toy industry
Molecular Response has introduced TargetX platform for the rapid discovery and validation of new oncology targets. The integrated platform, which features 144,000 living tumor specimens, genomic databases and patient derived tumor models, ...
Tags: TargetX platform, oncology targets
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Monteris Medical's NeuroBlate system for the treatment of brain tumors and other lesions. The MRI system embedded in the device provides visualization and allows ...
Clinigen has acquired Cardioxane (dexrazoxane) from Novartis for $33m, which is payable in two tranches. As per the agreement, Clinigen will manufacture, register, distribute, and commercialize the product in countries where current ...
Tags: Clinigen, Cardioxane, Medicine
US-based drug discovery and development service company Crown Bioscience and Horizon Discovery have entered into a two year collaboration agreement to provide combined solutions for in vivo model development. Under the partnership, ...
Astellas Pharma and Ambrx have collaborated to discover and develop new antibody drug conjugates (ADCs) for the targeted delivery of drugs into cancer tissues. Ambrx will use site-specific conjugation technology in addition to proprietary ...
Tags: Antibody Drug, Health, Medicine
The Indian Supreme Court has rejected Novartis' patent application for its anti-cancer drug Glivec (imatinib mesylate) saying that “application for patent on the beta-crystalline salt does not meet any standard of novelty or ...
Tags: Indian Apex, Novartis'Patent Plea, Glivec
The European Commission (EC) has granted conditional marketing authorization for Pfizer's Bosulif (bosutinib) anti-cancer drug in the European Union (EU). Bosulif is authorized in Europe for the treatment of adult patients with chronic ...
Tags: Pfizer Bosulif, cancer drug, drug
Biotechnology company bluebird bio has formed a broad collaboration with Celgene to develop new disease-altering gene therapies in oncology. The multi-year research and development collaboration aims to apply gene therapy technology to ...
The National Institute for Health and Clinical Excellence (NICE) in the UK, has issued an Appraisal Consultation Document (ACD) recommending that Afinitor (everolimus), a Novartis’ life extending advanced breast cancer treatment ...